$0.4950
At close: Mar 26, 5:00 PM EST

LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc. (LYRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-4.78 | $-4.83 | $-5.18 | $-6.83 |
| Actual | $-3.77 | $-3.38 | $-5.51 | $-6.50 |
| Surprise | +21.1% | +30.0% | -6.37% | +4.83% |
| Revenue | ||||
| Estimate | $187000 | $136550 | $168750 | $160000 |
| Actual | $7000 | $25000 | $183000 | $183000 |
| Surprise | -96.3% | -81.7% | +8.44% | +14.4% |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 31, 2026 | $-3.77 | $-4.78 | 21.1 % |
| Q3 | Nov 12, 2025 | $-3.38 | $-4.83 | 30.0 % |
| Q2 | Aug 12, 2025 | $-5.51 | $-5.18 | -6.37 % |
| Q1 | May 6, 2025 | $-6.50 | $-6.83 | 4.83 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 31, 2026 | $7.00K | $187.00K | -96.3 % |
| Q3 | Nov 12, 2025 | $25.00K | $136.55K | -81.7 % |
| Q2 | Aug 12, 2025 | $183.00K | $168.75K | 8.44 % |
| Q1 | May 6, 2025 | $183.00K | $160.00K | 14.4 % |